1 | class | 11,954 |
2 | laminae | 34 |
3 | atractylenolide | 30 |
4 | shriver | 24 |
5 | xeno | 24 |
6 | 'class | 12 |
7 | drb1*1501 | 9 |
8 | armin | 8 |
9 | st-ex | 8 |
10 | dipeptidylpeptidase | 7 |
11 | urogen | 7 |
12 | mutt | 6 |
13 | qolq | 6 |
14 | a01 | 5 |
15 | non-stage | 5 |
16 | umberto | 5 |
17 | e-technology | 4 |
18 | lipocortin | 4 |
19 | draf | 3 |
20 | paracetamol-sobrerol | 3 |
21 | progenin | 3 |
22 | vpf | 3 |
23 | β2-glycoprotein | 3 |
24 | 2.3+/-0.7 | 2 |
25 | 28-deglucosyl-chikusetsusaponin | 2 |
26 | apolipophorin | 2 |
27 | autocon | 2 |
28 | branca | 2 |
29 | fenpipramide | 2 |
30 | i-ang | 2 |
31 | i/group | 2 |
32 | phlorin | 2 |
33 | psychiatrii | 2 |
34 | v.4 | 2 |
35 | -deiodinase | 1 |
36 | -glaberide | 1 |
37 | /variolink | 1 |
38 | /β-2-glycoprotein | 1 |
39 | 0/cin | 1 |
40 | 11β,17β-isomer | 1 |
41 | 446.7 | 1 |
42 | 74,41 | 1 |
43 | a*0278/2631 | 1 |
44 | ache/che-is | 1 |
45 | agents-angioten | 1 |
46 | alkoholizm | 1 |
47 | anagrelide-aspirin | 1 |
48 | antitype | 1 |
49 | b*57 | 1 |
50 | baik-rains | 1 |
51 | bis-polyacetal | 1 |
52 | cefixime-amoxicilline/clavulanate | 1 |
53 | classe | 1 |
54 | clonidine-clonazepam | 1 |
55 | conjunctivitis-otitis | 1 |
56 | connectivity-areas | 1 |
57 | count-ma | 1 |
58 | c₂ | 1 |
59 | des-polyacetal | 1 |
60 | des-treatment | 1 |
61 | diacetates | 1 |
62 | diacetohydrazides | 1 |
63 | divalinal-ang | 1 |
64 | dna/fok | 1 |
65 | dyspepsia-quality | 1 |
66 | evidence-level | 1 |
67 | factors-clarity | 1 |
68 | fever/sounding | 1 |
69 | gomphrenin | 1 |
70 | gradeubavm | 1 |
71 | h-ang | 1 |
72 | h.group | 1 |
73 | i-cin | 1 |
74 | i-step | 1 |
75 | i/cin | 1 |
76 | i/level | 1 |
77 | ii-cin | 1 |
78 | ii-photosystem | 1 |
79 | ii/cin | 1 |
80 | increaseaegroup | 1 |
81 | index-mark | 1 |
82 | killip-class | 1 |
83 | medlite | 1 |
84 | method-as | 1 |
85 | minocycline/rifabutin | 1 |
86 | nephrectomy+tanshinone | 1 |
87 | outcome.fixation | 1 |
88 | questionnaire-bq | 1 |
89 | radiooncologists | 1 |
90 | rna-derived | 1 |
91 | scaleiaintracranial | 1 |
92 | shriven | 1 |
93 | stage-have | 1 |
94 | status/regulation | 1 |
95 | sub-obstruction | 1 |
96 | telomerase/topoisomerase | 1 |
97 | trial-s | 1 |
98 | trialmatch | 1 |
99 | triazolylidenes | 1 |
100 | trienal | 1 |
101 | uprds | 1 |
102 | vr/haptics | 1 |
1 | 'class | 12 |
2 | -deiodinase | 1 |
3 | -glaberide | 1 |
4 | /variolink | 1 |
5 | /β-2-glycoprotein | 1 |
6 | 0/cin | 1 |
7 | 11β,17β-isomer | 1 |
8 | 2.3+/-0.7 | 2 |
9 | 28-deglucosyl-chikusetsusaponin | 2 |
10 | 446.7 | 1 |
11 | 74,41 | 1 |
12 | a*0278/2631 | 1 |
13 | a01 | 5 |
14 | ache/che-is | 1 |
15 | agents-angioten | 1 |
16 | alkoholizm | 1 |
17 | anagrelide-aspirin | 1 |
18 | antitype | 1 |
19 | apolipophorin | 2 |
20 | armin | 8 |
21 | atractylenolide | 30 |
22 | autocon | 2 |
23 | b*57 | 1 |
24 | baik-rains | 1 |
25 | bis-polyacetal | 1 |
26 | branca | 2 |
27 | cefixime-amoxicilline/clavulanate | 1 |
28 | class | 11,954 |
29 | classe | 1 |
30 | clonidine-clonazepam | 1 |
31 | conjunctivitis-otitis | 1 |
32 | connectivity-areas | 1 |
33 | count-ma | 1 |
34 | c₂ | 1 |
35 | des-polyacetal | 1 |
36 | des-treatment | 1 |
37 | diacetates | 1 |
38 | diacetohydrazides | 1 |
39 | dipeptidylpeptidase | 7 |
40 | divalinal-ang | 1 |
41 | dna/fok | 1 |
42 | draf | 3 |
43 | drb1*1501 | 9 |
44 | dyspepsia-quality | 1 |
45 | e-technology | 4 |
46 | evidence-level | 1 |
47 | factors-clarity | 1 |
48 | fenpipramide | 2 |
49 | fever/sounding | 1 |
50 | gomphrenin | 1 |
51 | gradeubavm | 1 |
52 | h-ang | 1 |
53 | h.group | 1 |
54 | i-ang | 2 |
55 | i-cin | 1 |
56 | i-step | 1 |
57 | i/cin | 1 |
58 | i/group | 2 |
59 | i/level | 1 |
60 | ii-cin | 1 |
61 | ii-photosystem | 1 |
62 | ii/cin | 1 |
63 | increaseaegroup | 1 |
64 | index-mark | 1 |
65 | killip-class | 1 |
66 | laminae | 34 |
67 | lipocortin | 4 |
68 | medlite | 1 |
69 | method-as | 1 |
70 | minocycline/rifabutin | 1 |
71 | mutt | 6 |
72 | nephrectomy+tanshinone | 1 |
73 | non-stage | 5 |
74 | outcome.fixation | 1 |
75 | paracetamol-sobrerol | 3 |
76 | phlorin | 2 |
77 | progenin | 3 |
78 | psychiatrii | 2 |
79 | qolq | 6 |
80 | questionnaire-bq | 1 |
81 | radiooncologists | 1 |
82 | rna-derived | 1 |
83 | scaleiaintracranial | 1 |
84 | shriven | 1 |
85 | shriver | 24 |
86 | st-ex | 8 |
87 | stage-have | 1 |
88 | status/regulation | 1 |
89 | sub-obstruction | 1 |
90 | telomerase/topoisomerase | 1 |
91 | trial-s | 1 |
92 | trialmatch | 1 |
93 | triazolylidenes | 1 |
94 | trienal | 1 |
95 | umberto | 5 |
96 | uprds | 1 |
97 | urogen | 7 |
98 | v.4 | 2 |
99 | vpf | 3 |
100 | vr/haptics | 1 |
101 | xeno | 24 |
102 | β2-glycoprotein | 3 |
1 | drb1*1501 | 9 |
2 | a01 | 5 |
3 | a*0278/2631 | 1 |
4 | 74,41 | 1 |
5 | v.4 | 2 |
6 | 2.3+/-0.7 | 2 |
7 | 446.7 | 1 |
8 | b*57 | 1 |
9 | branca | 2 |
10 | count-ma | 1 |
11 | rna-derived | 1 |
12 | laminae | 34 |
13 | atractylenolide | 30 |
14 | fenpipramide | 2 |
15 | -glaberide | 1 |
16 | non-stage | 5 |
17 | nephrectomy+tanshinone | 1 |
18 | antitype | 1 |
19 | dipeptidylpeptidase | 7 |
20 | -deiodinase | 1 |
21 | telomerase/topoisomerase | 1 |
22 | classe | 1 |
23 | cefixime-amoxicilline/clavulanate | 1 |
24 | medlite | 1 |
25 | stage-have | 1 |
26 | draf | 3 |
27 | vpf | 3 |
28 | h-ang | 1 |
29 | i-ang | 2 |
30 | divalinal-ang | 1 |
31 | fever/sounding | 1 |
32 | trialmatch | 1 |
33 | psychiatrii | 2 |
34 | /variolink | 1 |
35 | dna/fok | 1 |
36 | index-mark | 1 |
37 | scaleiaintracranial | 1 |
38 | trienal | 1 |
39 | des-polyacetal | 1 |
40 | bis-polyacetal | 1 |
41 | evidence-level | 1 |
42 | i/level | 1 |
43 | paracetamol-sobrerol | 3 |
44 | clonidine-clonazepam | 1 |
45 | ii-photosystem | 1 |
46 | gradeubavm | 1 |
47 | alkoholizm | 1 |
48 | urogen | 7 |
49 | agents-angioten | 1 |
50 | shriven | 1 |
51 | i-cin | 1 |
52 | ii-cin | 1 |
53 | 0/cin | 1 |
54 | i/cin | 1 |
55 | ii/cin | 1 |
56 | /β-2-glycoprotein | 1 |
57 | β2-glycoprotein | 3 |
58 | armin | 8 |
59 | progenin | 3 |
60 | gomphrenin | 1 |
61 | 28-deglucosyl-chikusetsusaponin | 2 |
62 | anagrelide-aspirin | 1 |
63 | apolipophorin | 2 |
64 | phlorin | 2 |
65 | lipocortin | 4 |
66 | minocycline/rifabutin | 1 |
67 | autocon | 2 |
68 | status/regulation | 1 |
69 | outcome.fixation | 1 |
70 | sub-obstruction | 1 |
71 | xeno | 24 |
72 | umberto | 5 |
73 | i-step | 1 |
74 | h.group | 1 |
75 | i/group | 2 |
76 | increaseaegroup | 1 |
77 | questionnaire-bq | 1 |
78 | qolq | 6 |
79 | 11β,17β-isomer | 1 |
80 | shriver | 24 |
81 | trial-s | 1 |
82 | method-as | 1 |
83 | connectivity-areas | 1 |
84 | vr/haptics | 1 |
85 | uprds | 1 |
86 | diacetohydrazides | 1 |
87 | triazolylidenes | 1 |
88 | diacetates | 1 |
89 | ache/che-is | 1 |
90 | conjunctivitis-otitis | 1 |
91 | baik-rains | 1 |
92 | class | 11,954 |
93 | 'class | 12 |
94 | killip-class | 1 |
95 | radiooncologists | 1 |
96 | des-treatment | 1 |
97 | mutt | 6 |
98 | st-ex | 8 |
99 | e-technology | 4 |
100 | dyspepsia-quality | 1 |
101 | factors-clarity | 1 |
102 | c₂ | 1 |